Start an Independent Oncology Specialty Pharmacy

1. 1

   Get licensed and accredited

   A specialty pharmacy needs state pharmacy licensure in every state it ships to, plus specialty-pharmacy accreditation (commonly URAC and ACHC) that payers and manufacturers require to contract with you. Accreditation demands documented clinical programs, quality systems, and patient-management protocols. This is a months-long gate before you can dispense a single prescription.

2. 2

   Solve limited-distribution drug access

   Many oncology drugs are sold through limited or exclusive distribution networks, meaning the manufacturer restricts which pharmacies may dispense them. Getting into those networks is the make-or-break challenge for an independent, and manufacturers favor scaled, accredited partners. Without drug access there is no business, so pursue distribution agreements as the first priority, not an afterthought.

3. 3

   Win payer-network contracts

   Over 80 percent of managed care organizations contract specialty pharmacy providers, and many networks are already locked up by PBM-owned and wholesaler-owned pharmacies. You must contract with payers and PBMs to be reimbursed, and network access is competitive and often closed. This incumbent lock-in is the honest reason independents struggle.

4. 4

   Build the care-coordination layer

   The differentiator beyond dispensing is coordination: prior-authorization management, sourcing financial assistance and copay support, adherence monitoring, and side-effect management for patients on complex cancer regimens. This clinical service is where an independent can add real value and justify its role. Staff oncology-experienced pharmacists and nurses to deliver it.

5. 5

   Stand up compliant operations and technology

   Hazardous-drug handling under USP standards, cold-chain and specialty shipping, prior-auth and benefits-investigation workflows, and reporting back to manufacturers and payers all require serious systems. Drug inventory ties up significant working capital. Operational excellence and reporting are what keep the manufacturer and payer contracts you fought to win.

6. 6

   Choose a defensible niche and referral base

   Rather than competing head-on with national players across all cancers, many independents focus on specific tumor types, regional oncology-practice relationships, or superior service to a defined referral base. A tight relationship with oncology practices or a distinct clinical program can secure volume. Related cards cover the PBM-owned, wholesaler-owned, manufacturer-hub, and health-system-owned versions, which have very different access advantages.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.